| Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ... Neuro-oncology 22 (8), 1073-1113, 2020 | 808 | 2020 |
| Adult glioblastoma BM Alexander, TF Cloughesy Journal of Clinical Oncology 35 (21), 2402-2409, 2017 | 806 | 2017 |
| Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ... Neuro-oncology 17 (9), 1188-1198, 2015 | 674 | 2015 |
| Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study DN Cagney, AM Martin, PJ Catalano, AJ Redig, NU Lin, EQ Lee, PY Wen, ... Neuro-oncology 19 (11), 1511-1521, 2017 | 671 | 2017 |
| Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) PW Sperduto, TJ Yang, K Beal, H Pan, PD Brown, A Bangdiwala, ... JAMA oncology 3 (6), 827-831, 2017 | 651 | 2017 |
| Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis LM Spring, G Fell, A Arfe, C Sharma, R Greenup, KL Reynolds, BL Smith, ... Clinical cancer research 26 (12), 2838-2848, 2020 | 623 | 2020 |
| Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 493 | 2020 |
| Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations A Yang, NV Rajeshkumar, X Wang, S Yabuuchi, BM Alexander, GC Chu, ... Cancer discovery 4 (8), 905-913, 2014 | 475 | 2014 |
| Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin R Woodhouse, M Li, J Hughes, D Delfosse, J Skoletsky, P Ma, W Meng, ... PloS one 15 (9), e0237802, 2020 | 302 | 2020 |
| Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma M Abedalthagafi, WL Bi, AA Aizer, PH Merrill, R Brewster, PK Agarwalla, ... Neuro-oncology 18 (5), 649-655, 2016 | 287 | 2016 |
| Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation AM Martin, DN Cagney, PJ Catalano, BM Alexander, AJ Redig, ... JAMA oncology 4 (8), 1123-1124, 2018 | 285 | 2018 |
| Brain metastases in newly diagnosed breast cancer: a population-based study AM Martin, DN Cagney, PJ Catalano, LE Warren, JR Bellon, RS Punglia, ... JAMA oncology 3 (8), 1069-1077, 2017 | 285 | 2017 |
| Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas B Zhang, K Chang, S Ramkissoon, S Tanguturi, WL Bi, DA Reardon, ... Neuro-oncology 19 (1), 109-117, 2017 | 260 | 2017 |
| Adaptive platform trials: definition, design, conduct and reporting considerations Nature Reviews Drug Discovery 18 (10), 797-807, 2019 | 255 | 2019 |
| Updates in the management of brain metastases ND Arvold, EQ Lee, MP Mehta, K Margolin, BM Alexander, NU Lin, ... Neuro-oncology 18 (8), 1043-1065, 2016 | 250 | 2016 |
| A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab RA Chandra, TJ Wilhite, TA Balboni, BM Alexander, A Spektor, PA Ott, ... Oncoimmunology 4 (11), e1046028, 2015 | 243 | 2015 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 199 | 2021 |
| Future cancer research priorities in the USA: a Lancet Oncology Commission EM Jaffee, C Van Dang, DB Agus, BM Alexander, KC Anderson, ... The Lancet Oncology 18 (11), e653-e706, 2017 | 198 | 2017 |
| Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas GM Shankar, M Abedalthagafi, RA Vaubel, PH Merrill, N Nayyar, CM Gill, ... Neuro-oncology 19 (4), 535-545, 2017 | 195 | 2017 |
| Extent of resection and overall survival for patients with atypical and malignant meningioma AA Aizer, WL Bi, MS Kandola, EQ Lee, L Nayak, ML Rinne, AD Norden, ... Cancer 121 (24), 4376-4381, 2015 | 191 | 2015 |
Keith L. LigonAssociate Professor, Harvard Medical School在 dfci.harvard.edu 的电子邮件经过验证
